0001236031-18-000023.txt : 20180503 0001236031-18-000023.hdr.sgml : 20180503 20180503165931 ACCESSION NUMBER: 0001236031-18-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180501 FILED AS OF DATE: 20180503 DATE AS OF CHANGE: 20180503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Watson Robert Eugene CENTRAL INDEX KEY: 0001511858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 18804720 MAIL ADDRESS: STREET 1: 245 N. HIGHLAND AVE NE STREET 2: SUITE 230-296 CITY: ATLANTA STATE: 2Q ZIP: 30307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2018-05-01 0 0000725363 CEL SCI CORP CVM 0001511858 Watson Robert Eugene 245 N. HIGHLAND AVE NE SUITE 230-296 ATLANTA 2Q 30307 GEORGIA 1 0 0 0 Options 2.45 2018-05-01 4 A 0 80000 0.01 A 2028-04-30 Common Stock 80000 90000 D The stock options vest in three (3) equal annual installments commencing one year after the grant date. Robert Watson 2018-05-03